Respiratory tract infections remain a significant global health concern, necessitating the continuous development of effective antimicrobial therapies. Macrolide antibiotics have long been a cornerstone in treating these infections, and their complex structures require specific, high-quality intermediates for synthesis. Among these critical components is (2R)-2-Amino-3-benzyloxy-1-propanol (CAS 58577-87-0), a versatile organic building block.

The synthesis of 15-membered macrolide antibiotics, a class known for its broad-spectrum activity against various bacteria, heavily relies on chiral synthons. (2R)-2-Amino-3-benzyloxy-1-propanol provides a crucial chiral center and functional groups that are incorporated into the growing macrolide chain. The precise stereochemistry offered by this pharmaceutical intermediate is essential for the final antibiotic's ability to bind to bacterial ribosomes and inhibit protein synthesis, thereby combating infections.

NINGBO INNO PHARMCHEM CO.,LTD., as a prominent manufacturer in China, plays a pivotal role in supplying these vital intermediates. We understand the importance of reliability and purity when it comes to antibiotic synthesis. Our commitment to quality ensures that researchers and manufacturers can readily acquire (2R)-2-Amino-3-benzyloxy-1-propanol to support their drug development efforts. Whether you are looking to buy for research purposes or large-scale production, our supply ensures consistency.

The pharmaceutical intermediates provided by NINGBO INNO PHARMCHEM CO.,LTD. empower scientists to build complex molecular architectures efficiently. The application of (2R)-2-Amino-3-benzyloxy-1-propanol in macrolide antibiotic synthesis underscores its importance in public health, particularly in addressing infectious diseases affecting the respiratory system. The availability and competitive price of this key intermediate make it an attractive option for global pharmaceutical companies.